MECHANICALLY-INDUCED REMODELING OF TISSUE ENGINEERED BLOOD VESSELS

组织工程血管的机械诱导重塑

基本信息

  • 批准号:
    7500827
  • 负责人:
  • 金额:
    $ 18.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-09-01 至 2010-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): There is a great unmet clinical need to develop small diameter tissue engineered blood vessels (TEBV) with low thrombogenicity and immune response, suitable mechanical properties, and a capacity to remodel to their environment. Our central hypothesis is that axial extension will induce remodeling in collagen-fibrin TEBVs at rates that exceed that of pressure- or flow-induced remodeling and combining these multidirectional mechanical stimuli will increase remodeling rates beyond the additive response of these unidirectional stimuli alone. The goals of this proposal are (I) to develop and test an experimental device to that can precisely and independently control multidirectional mechanical loading and is capable of performing intermittent pressure- diameter (P-d) and axial force-length (f- changes in the biomechanical response and microstructural organization, respectively, at multiple time-points in culture, (ii) to develop a microstructurally-motivate computational model to describe TEBV remodeling to mechanical stimuli, and (iii) to employ these experimental and computational models to characterize remodeling of combined collagen-fibrin gel-derived TEBVs exposed to unidirectional and multidirectional loading. We will test our central hypothesis by characterize remodeling of collagen-fibrin gel-derived TEBVs exposed to gradual increases in (a) axial extension, (b) pulsatile pressure, (c) luminal flow, or (d) simultaneous increases in axial extension, pulsatile pressure, and luminal flow. Successful realization of these aims will establish an innovative new paradigm for evaluating the role of mechanical stimuli on TEBVs that integrates biomechanical stimulation, biomechanical testing, LSM, and computational modeling. One expected outcome will be to characterize, in parallel, the temporal changes in the biaxial stress-strain response and the amount and organization of collagen, elastin, glycosaminoglycans (GAGs), and smooth muscle in TEBVs exposed to gradual increases in unidirectional and multidirectional loading. Another expected outcome will be to demonstrate that axial mechanical stimulation and multidirectional stimulation will improve the rates of remodeling in TEBVs. A third expected outcome will be to develop a multi-scale microstructurally-motivated computational model for mechanically-induced remodeling of collagen-fibrin gel-derived TEBVs; such a model that can be used to motivate subsequent experiments to optimize loading strategies to effectively and efficiently achieve suitable mechanical properties of TEBVs. Overall, we will demonstrate the feasibility of combining theoretical modeling and experiments to optimize strategies to develop TEBVs in a time- and cost-efficient manner. Over half a million coronary by-pass procedures are performed in the United States each year, however many patients lack adequate autologous grafting tissue; there is a great unmet clinical need to develop small diameter tissue engineered blood vessels with low thrombogenicity and immune response, suitable mechanical properties, and a capacity to remodel to their environment that will be suitable for coronary by-pass surgery. The purpose of this work is to optimize the use of biomechanical stimuli, such as gradual pressurization and axial extension, to stimulate remodeling of TEBVs to optimize their mechanical properties for coronary by-pass grafting.
描述(由申请人提供):开发小直径组织工程血管(TEBV)具有巨大的未满足的临床需求,该血管具有低血栓形成性和免疫反应性、合适的机械性能以及重塑其环境的能力。我们的中心假设是,轴向延伸将以超过压力或流动诱导重塑的速率诱导胶原纤维蛋白 TEBV 重塑,并且结合这些多向机械刺激将增加重塑速率,超过这些单向刺激单独的加性反应。该提案的目标是(I)开发和测试一种实验装置,该装置可以精确、独立地控制多向机械载荷,并且能够分别在培养的多个时间点执行间歇压力-直径(P-d)和轴向力-长度(f-生物力学响应和微观结构组织的变化),(ii)开发一种微观结构驱动的计算模型来描述 TEBV 重塑机械刺激,以及(iii)利用这些实验和计算模型来表征暴露于单向和多向负载的组合胶原纤维蛋白凝胶衍生的 TEBV 的重塑。我们将通过表征胶原纤维蛋白凝胶衍生的 TEBV 的重塑来测试我们的中心假设,这些 TEBV 暴露于(a)轴向延伸的逐渐增加,(b) 脉动压力,(c) 腔内流量,或 (d) 轴向延伸、脉动压力和腔内流量同时增加。这些目标的成功实现将建立一个创新的新范式,用于评估机械刺激对 TEBV 的作用,该范式集成了生物力学刺激、生物力学测试、LSM 和计算建模。一个预期的结果将是同时描述 在单向和多向载荷逐渐增加的情况下,TEBV 中双轴应力-应变响应以及胶原蛋白、弹性蛋白、糖胺聚糖 (GAG) 和平滑肌的数量和组织的时间变化。另一个预期结果是证明轴向机械刺激和多向刺激将提高 TEBV 的重塑率。预计第三个 结果将是开发一个多尺度微观结构驱动的计算模型,用于胶原纤维蛋白凝胶衍生的 TEBV 的机械诱导重塑;这样的模型可用于激励后续实验来优化加载策略,以有效且高效地实现 TEBV 合适的机械性能。总的来说,我们将论证结合理论建模和实验来优化的可行性 以时间和成本高效的方式开发 TEBV 的策略。美国每年进行超过 50 万例冠状动脉搭桥手术,但许多患者缺乏足够的自体移植组织;开发小直径组织工程血管具有巨大的未满足的临床需求,该血管具有低血栓形成性和免疫反应性、合适的机械性能以及重塑适合冠状动脉搭桥的环境的能力 手术。这项工作的目的是优化生物力学刺激的使用,例如逐渐加压和轴向延伸,以刺激 TEBV 重塑,从而优化其用于冠状动脉搭桥术的机械性能。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A phenomenological model for mechanically mediated growth, remodeling, damage, and plasticity of gel-derived tissue engineered blood vessels.
用于机械介导的凝胶衍生组织工程血管的生长、重塑、损伤和可塑性的现象学模型。
  • DOI:
    10.1115/1.4000124
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Raykin,Julia;Rachev,AlexanderI;GleasonJr,RudolphL
  • 通讯作者:
    GleasonJr,RudolphL
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RUDOLPH L GLEASON其他文献

RUDOLPH L GLEASON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RUDOLPH L GLEASON', 18)}}的其他基金

PREVENTING MATERNAL MORTALITY FROM OBSTRUCTED LABOR
预防难产造成的孕产妇死亡
  • 批准号:
    10619512
  • 财政年份:
    2021
  • 资助金额:
    $ 18.18万
  • 项目类别:
PREVENTING MATERNAL MORTALITY FROM OBSTRUCTED LABOR
预防难产造成的孕产妇死亡
  • 批准号:
    10390445
  • 财政年份:
    2021
  • 资助金额:
    $ 18.18万
  • 项目类别:
A novel computing framework to automatically process cardiac valve image data and predict treatment outcomes
一种新颖的计算框架,可自动处理心脏瓣膜图像数据并预测治疗结果
  • 批准号:
    10162650
  • 财政年份:
    2018
  • 资助金额:
    $ 18.18万
  • 项目类别:
FIBULIN-5 & WALL STRESSES IN VASCULAR REMODELING: THEORY AND EX VIVO EXPERIMENTS
FIBULIN-5
  • 批准号:
    7499745
  • 财政年份:
    2007
  • 资助金额:
    $ 18.18万
  • 项目类别:
FIBULIN-5 & WALL STRESSES IN VASCULAR REMODELING: THEORY AND EX VIVO EXPERIMENTS
FIBULIN-5
  • 批准号:
    7254459
  • 财政年份:
    2007
  • 资助金额:
    $ 18.18万
  • 项目类别:
MECHANICALLY-INDUCED REMODELING OF TISSUE ENGINEERED BLOOD VESSELS
组织工程血管的机械诱导重塑
  • 批准号:
    7236882
  • 财政年份:
    2007
  • 资助金额:
    $ 18.18万
  • 项目类别:

相似海外基金

Phase I/II clinical trial of autologous T cell gene therapy to treat X-linked lymphoproliferative disease (XLP)
自体T细胞基因疗法治疗X连锁淋巴增殖性疾病(XLP)的I/II期临床试验
  • 批准号:
    MR/Y019458/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.18万
  • 项目类别:
    Research Grant
Fabrication and Evaluation of Poly(glycerol sebacate) based small diameter vascular graft as a potent substitution for autologous vessels
基于聚(甘油癸二酸酯)的小直径血管移植物作为自体血管有效替代品的制造和评估
  • 批准号:
    2897580
  • 财政年份:
    2023
  • 资助金额:
    $ 18.18万
  • 项目类别:
    Studentship
Autologous Bone Marrow Aspirate Concentrate for the Treatment of Osteonecrosis of the Femoral Head
自体骨髓抽吸浓缩液治疗股骨头坏死
  • 批准号:
    10658324
  • 财政年份:
    2023
  • 资助金额:
    $ 18.18万
  • 项目类别:
Identifying multimodal biomarkers for autologous serum tears in the treatment of chronic postoperative ocular pain
识别治疗慢性术后眼痛的自体血清泪液的多模式生物标志物
  • 批准号:
    10794761
  • 财政年份:
    2023
  • 资助金额:
    $ 18.18万
  • 项目类别:
SBIR Phase II: An Injectable Protein Matrix to Enhance the Stability of Autologous Fat Grafts
SBIR II 期:可注射蛋白质基质,增强自体脂肪移植物的稳定性
  • 批准号:
    2304430
  • 财政年份:
    2023
  • 资助金额:
    $ 18.18万
  • 项目类别:
    Cooperative Agreement
MICA: Strategy for heart repair in Duchenne Muscular Dystrophy (DMD) using genetically engineered autologous Mesoangioblasts
MICA:利用基因工程自体中成血管细胞修复杜氏肌营养不良症 (DMD) 的心脏的策略
  • 批准号:
    MR/X00466X/1
  • 财政年份:
    2023
  • 资助金额:
    $ 18.18万
  • 项目类别:
    Fellowship
Application of Autologous Connective Tissue Sheets Created in Patients' Bodies to Pediatric Cardiac Valvuloplasty and Development of Dedicated Molds
患者体内自体结缔组织片在小儿心脏瓣膜成形术中的应用及专用模具的开发
  • 批准号:
    23K15543
  • 财政年份:
    2023
  • 资助金额:
    $ 18.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
SBIR PHASE II, TOPIC 429: A NEW PARADIGM FOR AUTOLOGOUS AND ALLOGENEIC CELL THERAPY MANUFACTURING
SBIR 第二阶段,主题 429:自体和同种异体细胞治疗制造的新范式
  • 批准号:
    10976161
  • 财政年份:
    2023
  • 资助金额:
    $ 18.18万
  • 项目类别:
Planning a phase I study of minor salivary gland derived autologous MSCs for prevention of long-term radiation induced xerostomia
计划对小唾液腺来源的自体 MSC 进行 I 期研究,以预防长期辐射引起的口干症
  • 批准号:
    10720234
  • 财政年份:
    2023
  • 资助金额:
    $ 18.18万
  • 项目类别:
Evaluation of a therapeutic vaccination strategy with motif neoepitope peptide-pulsed autologous dendritic cells for non-small cell lung cancer patients harboring a charged HLA-B binding pocket.
使用基序新表位肽脉冲的自体树突状细胞对携带带电 HLA-B 结合袋的非小细胞肺癌患者的治疗性疫苗接种策略进行评估。
  • 批准号:
    10721983
  • 财政年份:
    2023
  • 资助金额:
    $ 18.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了